diet-drugs-pharmacy-phentermine
. Ionamin '15' and Ionamin '30' contain 15 mg and 30 mg respectively of phentermine as the cationic exchange resin complex. Inactive Ingredients: D&C Yellow No. Other central nervous system actions, or metabolic effects may be involved. Inactive Ingredients: D&C Yellow No. The bioavailability of Ionamin has been studied in humans in which blood levels of phentermine were measured by a gas chromatography method. The natural history of obesity is measured in years, whereas the studies cited are restricted to a few weeks' or months' duration; thus, the total impact of drug-induced weight loss over that of diet alone must be considered clinically limited. Tachyphylaxis and tolerance have been demonstrated with all drugs of this class in which these phenomena have been looked for. In clinical trials establishing the efficacy of Ionamin, a single daily dose produced an effect comparable to that produced by other regimens of "anorectic" drug therapy. Blood levels obtained with the 15 mg and 30 mg resin complex formulations indicated slower absorption with a reduced but prolonged peak concentration and without a significant difference in prolongation of blood levels when compared with the same doses of phentermine hydrochloride. Phentermine is , -dimethyl phenethylamine (phenyl-tertiary-butylamine). " It has not been established, however, that the action of such drugs in treating obesity is primarily one of appetite.
Ionamin '15' and Ionamin '30' contain 15 mg and.
